INCY
Incyte Corporation · Healthcare · Biotechnology
TECHSellZACKSHold
R500#456 today
$115.30
-1.57% today · -6.93% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- INCY −1.57% on the last session vs SPY +0.74%: −2.3 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 64 big drops in the past 5 years, INCY typically gained 0.7% over the next week (median) and was higher 56% of the time; half the outcomes fell between -1.7% and +2.4%. An ordinary week: +0.1%. Among S&P 500 stocks after big drops, that ranks #128 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
INCY against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #456 | -1.57% | +0.74% | |
| 1 week | #489 | -6.93% | -0.22% | |
| 1 month | #403 | -10.50% | +0.84% | |
| 3 months | #203 | -1.33% | +3.59% | |
| 6 months | #117 | +20.19% | +17.95% | |
| 1 year | #106 | +33.63% | +16.25% | |
| Overall | #331 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.12 | #372 | #3 |
| fPE/tPE | 0.88 | #373 | #4 |
| PE/G | 10.82 | #478 | #4 |
| EV/Revenue | 3.24 | #282 | #5 |
| Gross Margin | 0.56 | #169 | #2 |
| Profit Margin | 0.28 | #80 | #3 |
| Revenue Growth | 0.38 | #46 | #1 |